Project grant awarded by the Michael J Fox Foundation for the project entitled Modelling of the dimeric LRRK2 structure and characterization of the LRRK2
activation cycle: Allosteric targeting of LRRK2-mediated Parkinson's disease.
The project is executed with two partners in Germany (Tuebingen and Heidelberg).